Nano-level assay of attention-deficit/hyperactivity disorder medicament, atomoxetine by molecular-size-based resonance rayleigh scattering strategy. Employment in content uniformity, dosage form, and plasma analysis

Peer Review reports

Original Submission
22 Jul 2023	Submitted	Original manuscript
10 Aug 2023	Author responded	Author comments - Ahmed A Abu-hassan
26 Aug 2023	Reviewed	Reviewer Report
14 Sep 2023	Reviewed	Reviewer Report
18 Oct 2023	Author responded	Author comments - Ahmed A Abu-hassan
Resubmission - Version 2
10 Aug 2023	Submitted	Manuscript version 2
30 Oct 2023	Reviewed	Reviewer Report
30 Oct 2023	Reviewed	Reviewer Report
8 Nov 2023	Author responded	Author comments - Ahmed A Abu-hassan
Resubmission - Version 3
8 Nov 2023	Submitted	Manuscript version 3
Publishing
23 Nov 2023	Editorially accepted
6 Dec 2023	Article published	10.1186/s13065-023-01094-y

Back to article page